SCHEMBL6655017

SCHEMBL6655017

Nc1ccccc1Nc1ccc(C(=O)c2ccccc2O)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.72
MAPK12 P53778 10/20 0.72
MAPK11 Q15759 10/20 0.72
MAPK14 Q16539 10/20 0.72
LIG1 P18858 1/20 0.54
MAPT P10636 6/20 0.51
KDM4E B2RXH2 4/20 0.51
HPGD P15428 2/20 0.51
HSD17B10 Q99714 2/20 0.51
TP53 P04637 1/20 0.51
APP P05067 1/20 0.51
ALOX15 P16050 1/20 0.51
SNCA P37840 1/20 0.51
BLM P54132 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GAA P10253 5/20 0.50
ALDH1A1 P00352 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1905196 0.88 LIG1 (0.61) MAPK13MAPK12MAPK11MAPK14LIG1
SCHEMBL6655143 0.84 MAPK14 (0.71) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6656349 0.84 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6657232 0.84 MAPK14 (1.00) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6654082 0.84 MAPK13 (0.71) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6651304 0.83 LIG1 (0.59) MAPK13MAPK12MAPK11MAPK14LIG1
SCHEMBL27480922 0.83 MAPK13 (0.74) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL3978775 0.83 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6674463 0.82 MAPK13 (0.71) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL6655667 0.82 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966424-B1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMA AS (DK) 2004-06-23 EP disclosed
US-6313174-B1 FOR THERAPY AND PROPHYLAXIS OF ASTHMA, ALLERGY, RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, GOUT, ATHEROSCLEROSIS, CHRONIC INFLAMMATORY BOWEL DISEASE, PROLIFERATIVE AND INFLAMMATORY SKIN DISORDERS Leo Pharmaceutical Products Ltd.A/S/ (Løvens kemiske Fabrik Produktionsaktieselskab) (DK) 2001-11-06 US disclosed